Last reviewed · How we verify

NCT04617548

tDCS and CO-OP in Chronic Stroke

Completed Phase 1 Last updated 11 February 2022
What this trial tests

Phase 1 trial testing tDCS and CO-OP Group in Chronic Stroke in 8 participants. Completed in 1 January 2022.

Timeline
1 January 2020
Primary endpoint
31 December 2021
1 January 2022

Quick facts

Lead sponsorUniversity of Missouri-Columbia
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment8
Start date1 January 2020
Primary completion31 December 2021
Estimated completion1 January 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Missouri-Columbia

Who can join

Adults 30 to 80, any sex, with Chronic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project seeks to evaluate the acceptability feasibility, practicality feasibility, and preliminary effect of combining transcranial direct current stimulation (tDCS) and metacognitive strategy training (MCST) in individuals with chronic stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Stroke

Currently open trials in the same condition.

Other University of Missouri-Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04617548.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing